癌症免疫中对自身的免疫识别。
Immune recognition of self in immunity against cancer.
作者信息
Houghton Alan N, Guevara-Patiño José A
机构信息
The Swim Across America Laboratory of Tumor Immunology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
出版信息
J Clin Invest. 2004 Aug;114(4):468-71. doi: 10.1172/JCI22685.
Abstract
Most antigens expressed by human cancer cells and recognized by host T cells and antibodies are nonmutated self antigens — molecules also expressed on the surface of normal cells. These self antigens are ineffective at triggering immune responses against cancer cells, which provides one explanation for the difficulties in trying to immunize against human cancer. A new study describes how tumors can avoid recognition by the immune system and how enhancing the affinity of the interaction between a self antigen and the MHC-I molecule may lead to cancer immunity.
摘要
大多数由人类癌细胞表达并被宿主T细胞和抗体识别的抗原都是未突变的自身抗原——这些分子也在正常细胞表面表达。这些自身抗原在触发针对癌细胞的免疫反应方面无效，这为试图对人类癌症进行免疫接种所面临的困难提供了一种解释。一项新的研究描述了肿瘤如何避免被免疫系统识别，以及增强自身抗原与MHC-I分子之间相互作用的亲和力如何可能导致癌症免疫。
相似文献
1
Immune recognition of self in immunity against cancer.癌症免疫中对自身的免疫识别。
J Clin Invest. 2004 Aug;114(4):468-71. doi: 10.1172/JCI22685.
2
A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth.癌症患者和自身免疫性疾病患者存在一组共同的自身抗体：炎症在其诱导过程中的作用以及对肿瘤生长的影响。
Cancer Lett. 2009 Aug 18;281(1):8-23. doi: 10.1016/j.canlet.2008.11.009. Epub 2008 Dec 16.
3
T cells and tumours.T细胞与肿瘤
Nature. 2001 Jun 28;411(6841):1010-2. doi: 10.1038/35082676.
4
Cellular and humoral immune responses of cancer patients to defined tumor antigens.癌症患者对特定肿瘤抗原的细胞免疫和体液免疫反应。
Cancer Chemother Biol Response Modif. 2001;19:385-93.
5
Ovarian tumour antigens as potential targets for immune gene therapy.卵巢肿瘤抗原作为免疫基因治疗的潜在靶点。
Gene Ther. 1995 Jan;2(1):7-15.
6
Foreignness as a matter of degree: the relative immunogenicity of peptide/MHC ligands.作为程度问题的异己性：肽/MHC配体的相对免疫原性
J Theor Biol. 2004 Dec 21;231(4):535-48. doi: 10.1016/j.jtbi.2004.07.008.
7
The allogeneic response and tumor immunity.同种异体反应与肿瘤免疫。
Nat Med. 2001 Jun;7(6):649-52. doi: 10.1038/89008.
8
Mechanisms of immunity in cancer.癌症中的免疫机制。
Pathobiol Annu. 1981;11:155-75.
9
How a home-grown T cell receptor interacts with a foreign landscape.一个内源性T细胞受体如何与外来环境相互作用。
Cell. 2007 Apr 6;129(1):19-20. doi: 10.1016/j.cell.2007.03.018.
10
T-cell recognition of self peptides as tumor rejection antigens.T细胞将自身肽识别为肿瘤排斥抗原。
Immunol Res. 1996;15(3):179-90. doi: 10.1007/BF02918248.
引用本文的文献
1
Inhibitory leukocyte immunoglobulin-like receptors, subfamily B (LILRBs) in human diseases: structure, roles, mechanisms, and clinical applications.人类疾病中的抑制性白细胞免疫球蛋白样受体B亚家族（LILRBs）：结构、作用、机制及临床应用
Theranostics. 2025 Jul 25;15(16):8222-8258. doi: 10.7150/thno.116951. eCollection 2025.
2
Association between neutrophil-lymphocyte ratio and female breast cancer: an observational study from NHANES 2001-2018 with external validation.中性粒细胞与淋巴细胞比值和女性乳腺癌之间的关联：一项基于2001 - 2018年美国国家健康与营养检查调查（NHANES）的观察性研究及外部验证
Front Oncol. 2025 Jul 8;15:1564238. doi: 10.3389/fonc.2025.1564238. eCollection 2025.
3
Immune Cytolytic Activity and Strategies for Therapeutic Treatment.免疫细胞溶解活性与治疗策略。
Int J Mol Sci. 2024 Mar 23;25(7):3624. doi: 10.3390/ijms25073624.
4
Identifying cancer-associated leukocyte profiles using high-resolution flow cytometry screening and machine learning.使用高分辨率流式细胞术筛选和机器学习来鉴定癌症相关的白细胞谱。
Front Immunol. 2023 Aug 3;14:1211064. doi: 10.3389/fimmu.2023.1211064. eCollection 2023.
5
Exhausted T cells hijacking the cancer-immunity cycle: Assets and liabilities.耗尽的 T 细胞劫持癌症免疫周期：利弊兼具。
Front Immunol. 2023 Apr 14;14:1151632. doi: 10.3389/fimmu.2023.1151632. eCollection 2023.
6
Importance of Extracellular Vesicle Derived RNAs as Critical Colorectal Cancer Biomarkers.细胞外囊泡衍生RNA作为关键结直肠癌生物标志物的重要性。
ACS Bio Med Chem Au. 2022 Mar 1;2(3):222-235. doi: 10.1021/acsbiomedchemau.1c00043. eCollection 2022 Jun 15.
7
Boosting the Immune Response-Combining Local and Immune Therapy for Prostate Cancer Treatment.增强免疫反应——联合局部免疫疗法治疗前列腺癌。
Cells. 2022 Sep 7;11(18):2793. doi: 10.3390/cells11182793.
8
A novel monoclonal antibody associated with glucoside kills gastric adenocarcinoma AGS cells based on glycosylation target.一种与糖苷相关的新型单克隆抗体基于糖基化靶点杀伤胃腺癌 AGS 细胞。
J Cell Mol Med. 2022 Sep;26(18):4781-4791. doi: 10.1111/jcmm.17504. Epub 2022 Aug 9.
9
CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma.CFI-402257，一种 TTK 抑制剂，能有效抑制肝癌。
Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2119514119. doi: 10.1073/pnas.2119514119. Epub 2022 Aug 1.
10
Inflammation-based Indexes Upon Adjuvant Chemotherapy Initiation as a Predictor of Relapse After Curative Resection of Colorectal Cancer With an Oxaliplatin-based Regimen.辅助化疗开始时基于炎症的指标作为接受奥沙利铂方案根治性切除的结直肠癌复发的预测指标。
Cancer Diagn Progn. 2022 Jan 3;2(1):64-70. doi: 10.21873/cdp.10077. eCollection 2022 Jan-Feb.
本文引用的文献
1
Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance.自身/肿瘤抗原的免疫原性差源于肽-MHC-I的不稳定性，且与耐受性无关。
J Clin Invest. 2004 Aug;114(4):551-9. doi: 10.1172/JCI21695.
2
Rituximab: expanding role in therapy for lymphomas and autoimmune diseases.利妥昔单抗：在淋巴瘤和自身免疫性疾病治疗中的作用不断扩展。
Annu Rev Med. 2004;55:477-503. doi: 10.1146/annurev.med.55.091902.104249.
3
Immunological recognition of self.自身的免疫识别
Science. 1961 Feb 3;133(3449):307-11. doi: 10.1126/science.133.3449.307.
4
Immunity to methylcholanthrene-induced sarcomas.对甲基胆蒽诱导肉瘤的免疫性。
J Natl Cancer Inst. 1957 Jun;18(6):769-78.
5
A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen.单个交叉反应性表位决定异种DNA免疫肿瘤分化抗原后的癌症免疫。
J Immunol. 2003 May 15;170(10):5188-94. doi: 10.4049/jimmunol.170.10.5188.
6
Rules for making human tumor cells.制造人类肿瘤细胞的规则。
N Engl J Med. 2002 Nov 14;347(20):1593-603. doi: 10.1056/NEJMra021902.
7
Immunity against cancer: lessons learned from melanoma.抗癌免疫：从黑色素瘤中汲取的经验教训。
Curr Opin Immunol. 2001 Apr;13(2):134-40. doi: 10.1016/s0952-7915(00)00195-3.
8
Coupling and uncoupling of tumor immunity and autoimmunity.肿瘤免疫与自身免疫的偶联和解偶联。
J Exp Med. 1999 Dec 6;190(11):1717-22. doi: 10.1084/jem.190.11.1717.
9
Heteroclitic immunization induces tumor immunity.异种免疫诱导肿瘤免疫。
J Exp Med. 1998 Nov 2;188(9):1553-61. doi: 10.1084/jem.188.9.1553.
10
Tumor immunity and autoimmunity induced by immunization with homologous DNA.同源DNA免疫诱导的肿瘤免疫和自身免疫
J Clin Invest. 1998 Sep 15;102(6):1258-64. doi: 10.1172/JCI4004.
Zotero 插件